News Image

IROQUOIS CAPITAL NOMINATES SLATE OF HIGHLY QUALIFIED DIRECTOR CANDIDATES FOR ELECTION AT PHARMACYTE'S 2022 ANNUAL MEETING

Provided By PR Newswire

Last update: Jun 23, 2022

Believes Truly Independent Board Required to Increase Accountability Given PharmaCyte's Long History of Missed Milestones

Highlights Severe Governance Deficiencies and Recent Half-Baked Efforts to Appease Stockholders

Read more at prnewswire.com

PHARMACYTE BIOTECH INC

NASDAQ:PMCB (8/15/2025, 8:00:00 PM)

After market: 0.8998 0 (-0.01%)

0.8999

+0.01 (+1.25%)



Find more stocks in the Stock Screener

Follow ChartMill for more